EUVIMEDEUVIMED entdecken
Querschnittstudie

Biochemical Profile Of Mineral Bone Disease In Chronic Kidney Disease Patients And Correlation With Different Stages Of CKD – A Cross-Sectional Study

Bibhu Prasad Behera, Anuj Kumar Padhy, Sheshadev Kumbhar, Sarata Chandra Singh

IOSR Journal of Dental and Medical Sciences · 2026-01 · 25 (1) · 39-45

DOI: 10.9790/0853-2501033945 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-01. Verfasst von Bibhu Prasad Behera und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In the 21st century, Chronic kidney disease (CKD) has emerged as one of the most important causes of fatality and suffering, a progressive condition that involves nearly 80 crore individuals of the general population universally. The worldwide median prevalence of CKD is 9.5%. This study aims to study the patterns of various bone mineral abnormalities in different stages of CKD patients.

Methods

Patients of more than 18 years of age with CKD admitted in wards in SCB Medical College and Hospital, Cuttack, under the Department of Medicine and Department of Nephrology from June 2021 to December 2022 will be included after satisfying the inclusion and exclusion criteria for the cross-sectional study. Inclusion criteria: Pre-dialytic CKD patients of more than 18 years of age are included. Exclusion criteria: Patients already on dialysis and transplant patients, patients with known parathyroid abnormalities, patients who are taking NSAIDS, anti-epileptics, known liver diseases, rickets, osteomalacia patients, and patients with known disease of the thyroid and adrenal gland are excluded from this study.

Results

The prevalence of hyperparathyroidism in stages 3, 4 & 5 CKD is 52%, 58.82% & 87.5%, respectively. The prevalence of hyperphosphatemia in stage 3, 4 & 5 CKD is 4%, 17.65% & 50%, respectively.

Conclusion

This study concluded that the vitamin D deficiency pattern was more marked in early CKD than in late stages. Serum bone markers should be done during the screening of CKD-MBD patients, as the serum bone markers have a definite correlation with CKD-MBD patients.

Zitieren

APA

Behera, B. P., Padhy, A. K., Kumbhar, S., & Singh, S. C. (2026). Biochemical Profile Of Mineral Bone Disease In Chronic Kidney Disease Patients And Correlation With Different Stages Of CKD – A Cross-Sectional Study. IOSR Journal of Dental and Medical Sciences, 25(1), 39-45. https://doi.org/10.9790/0853-2501033945

Vancouver

Behera BP, Padhy AK, Kumbhar S, Singh SC. Biochemical Profile Of Mineral Bone Disease In Chronic Kidney Disease Patients And Correlation With Different Stages Of CKD – A Cross-Sectional Study. IOSR Journal of Dental and Medical Sciences. 2026;25(1):39-45. doi:10.9790/0853-2501033945

BibTeX
@article{Behera2026,
  author = {Behera, Bibhu Prasad and Padhy, Anuj Kumar and Kumbhar, Sheshadev and Singh, Sarata Chandra},
  title = {Biochemical Profile Of Mineral Bone Disease In Chronic Kidney Disease Patients And Correlation With Different Stages Of CKD – A Cross-Sectional Study},
  journal = {IOSR Journal of Dental and Medical Sciences},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {39--45},
  doi = {10.9790/0853-2501033945}
}
Kostenlos starten →